110 likes | 111 Views
The companion diagnostics (CDx) market is projected to grow at a CAGR of 13.14% to reach US$8.974 billion by 2024, from US$4.278 billion in 2018. The growing prevalence of chronic disorders and the improving regulatory framework for supporting drug-diagnostic co-development models are driving the growth of the global companion diagnostics market.
E N D
Companion Diagnostics Market Forecast From 2019 to 2024
DESCRIPTION As per the latest reports by Knowledge Sourcing Intelligence, The companion diagnostics (CDx) market is projected to grow at a CAGR of 13.14% to reach US$8.974 billion by 2024, from US$4.278 billion in 2018. A companion diagnostic is a medical device, often an in vitro device (IVD), which provides information that is essential for the safe and effective use of a corresponding drug or biological product (source: FDA). The growing prevalence of chronic disorders and the improving regulatory framework for supporting drug-diagnostic co-development models are driving the growth of the global companion diagnostics (CDx) market. The advent of precision medicine and precision medicine diagnostics improving the quality of a patient’s life will further fuel the growth of the global companion diagnostics market in the forecast period and beyond.
Key Questions Answered By The Report • What will be Companion Diagnostics Marketfrom 2019 to 2024? • How are the major drivers and restraints affecting the Companion Diagnostics Market? • growth and the opportunities which exist for key vendors? • Which segment and region will drive or lead the market growth and why? • A comprehensive analysis of competitive landscape and key market participant’s behavior • Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth
Segments Covered Under Companion Diagnostics Market are : • By Technology • Polymerase Chain Reaction (PCR) • Immunohistochemistry (IHC) • In-situ Hybridization (ISH) • Next-Generation Sequencing (NGS) • By Indication • Lung Cancer • Breast Cancer • Colorectal Cancer • Other Oncology and non-oncology diseases
Geography • North America • United States • Canada • Mexico • South America • Brazil • Argentina • Others • Europe • United Kingdom • Germany • France • Italy • Others
Geography • Middle East and Africa • Saudi Arabia • Israel • Others • Asia Pacific • China • Japan • India • South Korea • Others
COMPANY PROFILES • Abbott Laboratories • Agilent Technologies, Inc. • ARUP Laboratories • F. Hoffmann-La Roche Ltd • Illumina, Inc. • Invivoscribe • Myriad Genetics, Inc. • QIAGEN • Thermo Fisher Scientific Inc.
TO ORDER OR REQUEST FOR A SAMPLE: Companion Diagnostics Market– Forecasts from 2019 to 2024 Link : https://www.knowledge-sourcing.com/report/companion-diagnostics-cdx-market Price: US$3,950 – Single User License US$4,550 – Multi User License US$6,950 – Enterprise License Payment: To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with payment. For wire transfer, write to us at sales@knowledge-sourcing.com For any custom requirements or queries, please visit our website or call us: Website: www.knowledge-sourcing.com Phone: +1-850-250-1698
Contact Us Address Knowledge Sourcing Intelligence LLPSuite 406, BSI Business ParkH-140, Sector 63 Noida, U.P. - 201301India Phone: +1-850-250-1698 Email info@knowledge-sourcing.com Visit us : https://www.knowledge-sourcing.com
Follow Us: Press Releases and Blogs: Click Here…
THANK YOU